5-Minute Summary: Does Preoperative Suzetrigine Impact ASC Opioid Consumption For Total Joint Arthroplasty? episode artwork

EPISODE · Jun 3, 2026 · 6 MIN

5-Minute Summary: Does Preoperative Suzetrigine Impact ASC Opioid Consumption For Total Joint Arthroplasty?

from JOEI The Journal · host Ira H. Kirschenbaum, MD

Total knee arthroplasty (TKA) and total hip arthroplasty (THA) are some of the most commonly performed surgical procedures. Due to the soft tissue damage sustained intraoperatively, pain is a common occurrence which is frequently treated with opioid analgesics. Conventional wisdom still espouses large numbers of opioids for post-op pain relief. However, opioid related adverse events such as addiction, mental status changes, fall risk, and sedation remain a problem. Suzetrigine is a novel non-addictive FDA approved medication to treat acute pain. Lowering opioid use in the early phases of recovery has been shown to reduce long-term opioid use for patients.

Episode metadata supplied by the publisher feed · Published Jun 3, 2026

Embed this episode

NOW PLAYING

5-Minute Summary: Does Preoperative Suzetrigine Impact ASC Opioid Consumption For Total Joint Arthroplasty?

0:00 6:21

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of JOEI The Journal?

This episode is 6 minutes long.

When was this JOEI The Journal episode published?

This episode was published on June 3, 2026.

Can I download this JOEI The Journal episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!